For instance, in gastric cancer, it promotes lactylation at the K229 site of METTL16, which in turn mediates the m6A modification on FDX1 mRNA, thereby enhancing cuproptosis (Sun et al., 2023). This evidence concerns the gene FDX1 and gastric cancer.